Position in ILMN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$465,922
+$264,461 QoQ
Shares Held
3,780
+146.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Gibbs Wealth Management holds $3,954,246 across 6 Diagnostics & Research names. ILMN ranks #5 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,074 | $1,510,963 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
1,500 | $842,835 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
1,221 | $586,311 | |
| 4 | GH |
Guardant Health, Inc.
|
5,935 | $548,215 | |
| 5 | ILMN |
Illumina, Inc.
This page
|
3,780 | $465,922 | |
| 6 | ADPT |
Adaptive Biotechnologies Corp
|
6,898 | $0 |
All Filings in ILMN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $465,922 | 3,780 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $201,461 | 1,536 | Shares | Other | 2026-01-23 | |
| No filing history on record for this holder in this stock. | ||||||